Santhera
is a Switzerland-based pharmaceutical company that develops and commercializes medicines for the treatment of neuromuscular and pulmonary diseases... Read moreSanthera
is a Switzerland-based pharmaceutical company that develops and commercializes medicines for the treatment of neuromuscular and pulmonary diseases... Read more
News
May 05, 2026
GlobeNewswire
Press Release: Santhera : Santhera Publishes Agenda for its Annual General Meeting
Apr 30, 2026
Benzinga
Santhera: Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Apr 28, 2026
centralcharts
Press Release: Santhera : Santhera Pharmaceuticals CFO on strong FY25 performance & AGAMREE expansion
Apr 28, 2026
Seeking Alpha
Santhera: Santhera Pharmaceuticals Holding AG 2025 Q4 - Results - Earnings Call Presentation
Apr 28, 2026
Proactive Investors
Santhera: Santhera reconfirms cash flow breakeven target as AGAMREE revenues near-double
Apr 28, 2026
FinanzNachrichten
Santhera: Santhera Pharmaceuticals Holding AG: Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE (vamorolone) in Italy
Apr 27, 2026
Nasdaq
Santhera: Santhera Moves Closer To Earlier Treatment Access For Young DMD Patients In Europe
Apr 27, 2026
Proactive Investors
Santhera: Santhera wins backing to extend DMD drug AGAMREE to toddlers as young as two
Apr 23, 2026
FinanzNachrichten
Santhera: Santhera Pharmaceuticals Holding AG: Santhera Appoints Orlando Oliveira as Chief Executive Officer
Mar 12, 2026
FinanzNachrichten
Santhera: Santhera Pharmaceuticals Holding AG: Full Year 2025 Trading Update
Santhera Competitors
1
2
3
4
5
6
7
8
9
10